This company working on a Covid-19 treatment involving SARS antibodies

Distributed Bio is creating a treatment for Covid-19 patients using antibodies from SARS patients. Jake Glanville, Distributed Bio CEO and founder, joins 'Closing Bell' to discuss the antibody treatment.